| Symbol |
Name |
|
ABCA1
|
ATP-binding cassette, sub-family A (ABC1), member 1
|
|
ABCA4
|
ATP-binding cassette, sub-family A (ABC1), member 4
|
|
ABCA7
|
ATP-binding cassette, sub-family A (ABC1), member 7
|
|
ABCB1
|
ATP-binding cassette, sub-family B (MDR/TAP), member 1
|
|
ABCC6
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 6
|
|
ABCD1
|
ATP-binding cassette, sub-family D (ALD), member 1
|
|
ABCG2
|
ATP-binding cassette, sub-family G (WHITE), member 2 (Junior blood group)
|
|
ABCG5
|
ATP-binding cassette, sub-family G (WHITE), member 5
|
|
ABCG8
|
ATP-binding cassette, sub-family G (WHITE), member 8
|
|
ABL1
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
|
ACAD9
|
acyl-CoA dehydrogenase family, member 9
|
|
ACSL3
|
acyl-CoA synthetase long-chain family member 3
|
|
ACSL5
|
acyl-CoA synthetase long-chain family member 5
|
|
ACTBP2
|
actin, beta pseudogene 2
|
|
ADAM12
|
ADAM metallopeptidase domain 12
|
|
ADD2
|
adducin 2 (beta)
|
|
ADIPOQ
|
adiponectin, C1Q and collagen domain containing
|
|
ADM
|
adrenomedullin
|
|
ADORA2A
|
adenosine A2a receptor
|
|
ADRB1
|
adrenoceptor beta 1
|
|
ADRB3
|
adrenoceptor beta 3
|
|
AGER
|
advanced glycosylation end product-specific receptor
|
|
AGTR1
|
angiotensin II receptor, type 1
|
|
AHCY
|
adenosylhomocysteinase
|
|
AIP
|
aryl hydrocarbon receptor interacting protein
|
|
AIRE
|
autoimmune regulator
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
ALAD
|
aminolevulinate dehydratase
|
|
ALDH1A3
|
aldehyde dehydrogenase 1 family, member A3
|
|
ALK
|
anaplastic lymphoma receptor tyrosine kinase
|
|
ALMS1
|
Alstrom syndrome protein 1
|
|
AMD1
|
adenosylmethionine decarboxylase 1
|
|
AMH
|
anti-Mullerian hormone
|
|
ANGPT1
|
angiopoietin 1
|
|
ANGPT2
|
angiopoietin 2
|
|
ANK1
|
ankyrin 1, erythrocytic
|
|
ANXA2
|
annexin A2
|
|
ANXA3
|
annexin A3
|
|
APAF1
|
apoptotic peptidase activating factor 1
|
|
APC
|
adenomatous polyposis coli
|
|
APEX1
|
APEX nuclease (multifunctional DNA repair enzyme) 1
|
|
APEX2
|
APEX nuclease (apurinic/apyrimidinic endonuclease) 2
|
|
APOA1
|
apolipoprotein A-I
|
|
APOA4
|
apolipoprotein A-IV
|
|
APOA5
|
apolipoprotein A-V
|
|
APOB
|
apolipoprotein B
|
|
APOBEC3F
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3F
|
|
APOBEC3G
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3G
|
|
APOC1
|
apolipoprotein C-I
|
|
APOE
|
apolipoprotein E
|
|
APOH
|
apolipoprotein H (beta-2-glycoprotein I)
|
|
APP
|
amyloid beta (A4) precursor protein
|
|
AQP2
|
aquaporin 2 (collecting duct)
|
|
AQP4
|
aquaporin 4
|
|
AR
|
androgen receptor
|
|
ARHGEF6
|
Rac/Cdc42 guanine nucleotide exchange factor (GEF) 6
|
|
ARID1A
|
AT rich interactive domain 1A (SWI-like)
|
|
ARID1B
|
AT rich interactive domain 1B (SWI1-like)
|
|
ARMS2
|
age-related maculopathy susceptibility 2
|
|
ARSA
|
arylsulfatase A
|
|
ARVCF
|
armadillo repeat gene deleted in velocardiofacial syndrome
|
|
ARX
|
aristaless related homeobox
|
|
AS3MT
|
arsenite methyltransferase
|
|
ATF4
|
activating transcription factor 4
|
|
ATL1
|
atlastin GTPase 1
|
|
ATM
|
ATM serine/threonine kinase
|
|
ATP13A2
|
ATPase type 13A2
|
|
ATP1A2
|
ATPase, Na+/K+ transporting, alpha 2 polypeptide
|
|
ATP7B
|
ATPase, Cu++ transporting, beta polypeptide
|
|
ATR
|
ATR serine/threonine kinase
|
|
AURKA
|
aurora kinase A
|
|
AVP
|
arginine vasopressin
|
|
BAAT
|
bile acid CoA:amino acid N-acyltransferase
|
|
BAX
|
BCL2-associated X protein
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BCL2L1
|
BCL2-like 1
|
|
BCL2L11
|
BCL2-like 11 (apoptosis facilitator)
|
|
BCR
|
breakpoint cluster region
|
|
BDNF
|
brain-derived neurotrophic factor
|
|
BGN
|
biglycan
|
|
BID
|
BH3 interacting domain death agonist
|
|
BIRC5
|
baculoviral IAP repeat containing 5
|
|
BLK
|
BLK proto-oncogene, Src family tyrosine kinase
|
|
BMP15
|
bone morphogenetic protein 15
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
|
BRCA1
|
breast cancer 1, early onset
|
|
BRCA2
|
breast cancer 2, early onset
|
|
BSG
|
basigin (Ok blood group)
|
|
BTG2
|
BTG family, member 2
|
|
BTK
|
Bruton agammaglobulinemia tyrosine kinase
|
|
C1D
|
C1D nuclear receptor corepressor
|
|
C3
|
complement component 3
|
|
C4A
|
complement component 4A (Rodgers blood group)
|
|
C4B
|
complement component 4B (Chido blood group)
|
|
C6
|
complement component 6
|
|
C9ORF72
|
chromosome 9 open reading frame 72
|
|
CA2
|
carbonic anhydrase II
|
|
CA5A
|
carbonic anhydrase VA, mitochondrial
|
|
CA5B
|
carbonic anhydrase VB, mitochondrial
|
|
CA9
|
carbonic anhydrase IX
|
|
CALCA
|
calcitonin-related polypeptide alpha
|
|
CALR
|
calreticulin
|
|
CAMP
|
cathelicidin antimicrobial peptide
|
|
CARD11
|
caspase recruitment domain family, member 11
|
|
CASP8
|
caspase 8, apoptosis-related cysteine peptidase
|
|
CASR
|
calcium-sensing receptor
|
|
CAT
|
catalase
|
|
CAV1
|
caveolin 1, caveolae protein, 22kDa
|
|
CAV3
|
caveolin 3
|
|
CBL
|
Cbl proto-oncogene, E3 ubiquitin protein ligase
|
|
CBS
|
cystathionine-beta-synthase
|
|
CCK
|
cholecystokinin
|
|
CCL17
|
chemokine (C-C motif) ligand 17
|
|
CCL2
|
chemokine (C-C motif) ligand 2
|
|
CCL5
|
chemokine (C-C motif) ligand 5
|
|
CCNB2
|
cyclin B2
|
|
CCND1
|
cyclin D1
|
|
CCR5
|
chemokine (C-C motif) receptor 5 (gene/pseudogene)
|
|
CCT6B
|
chaperonin containing TCP1, subunit 6B (zeta 2)
|
|
CD14
|
CD14 molecule
|
|
CD164
|
CD164 molecule, sialomucin
|
|
CD177
|
CD177 molecule
|
|
CD19
|
CD19 molecule
|
|
CD209
|
CD209 molecule
|
|
CD34
|
CD34 molecule
|
|
CD36
|
CD36 molecule (thrombospondin receptor)
|
|
CD38
|
CD38 molecule
|
|
CD4
|
CD4 molecule
|
|
CD40
|
CD40 molecule, TNF receptor superfamily member 5
|
|
CD44
|
CD44 molecule (Indian blood group)
|
|
CD55
|
CD55 molecule, decay accelerating factor for complement (Cromer blood group)
|
|
CD68
|
CD68 molecule
|
|
CD74
|
CD74 molecule, major histocompatibility complex, class II invariant chain
|
|
CD86
|
CD86 molecule
|
|
CD99
|
CD99 molecule
|
|
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial)
|
|
CDH3
|
cadherin 3, type 1, P-cadherin (placental)
|
|
CDK4
|
cyclin-dependent kinase 4
|
|
CDK5RAP3
|
CDK5 regulatory subunit associated protein 3
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CDKN2C
|
cyclin-dependent kinase inhibitor 2C (p18, inhibits CDK4)
|
|
CDR2
|
cerebellar degeneration-related protein 2, 62kDa
|
|
CEACAM5
|
carcinoembryonic antigen-related cell adhesion molecule 5
|
|
CELF1
|
CUGBP, Elav-like family member 1
|
|
CENPO
|
centromere protein O
|
|
CERS3
|
ceramide synthase 3
|
|
CETP
|
cholesteryl ester transfer protein, plasma
|
|
CFH
|
complement factor H
|
|
CFI
|
complement factor I
|
|
CFL1
|
cofilin 1 (non-muscle)
|
|
CFTR
|
cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)
|
|
CHAT
|
choline O-acetyltransferase
|
|
CHCHD4
|
coiled-coil-helix-coiled-coil-helix domain containing 4
|
|
CHEK1
|
checkpoint kinase 1
|
|
CHEK2
|
checkpoint kinase 2
|
|
CHRNA3
|
cholinergic receptor, nicotinic, alpha 3 (neuronal)
|
|
CHRNA7
|
cholinergic receptor, nicotinic, alpha 7 (neuronal)
|
|
CHRNA9
|
cholinergic receptor, nicotinic, alpha 9 (neuronal)
|
|
CLCN1
|
chloride channel, voltage-sensitive 1
|
|
CLDN2
|
claudin 2
|
|
CLDN3
|
claudin 3
|
|
CLDN4
|
claudin 4
|
|
CLDN5
|
claudin 5
|
|
CLDN7
|
claudin 7
|
|
CLSPN
|
claspin
|
|
CLU
|
clusterin
|
|
CNGA1
|
cyclic nucleotide gated channel alpha 1
|
|
CNR1
|
cannabinoid receptor 1 (brain)
|
|
CNTF
|
ciliary neurotrophic factor
|
|
COL1A1
|
collagen, type I, alpha 1
|
|
COL2A1
|
collagen, type II, alpha 1
|
|
COL6A4P1
|
collagen, type VI, alpha 4 pseudogene 1
|
|
COL7A1
|
collagen, type VII, alpha 1
|
|
COMT
|
catechol-O-methyltransferase
|
|
COTL1
|
coactosin-like F-actin binding protein 1
|
|
COX18
|
COX18 cytochrome c oxidase assembly factor
|
|
CPT2
|
carnitine palmitoyltransferase 2
|
|
CR1
|
complement component (3b/4b) receptor 1 (Knops blood group)
|
|
CRABP2
|
cellular retinoic acid binding protein 2
|
|
CREB1
|
cAMP responsive element binding protein 1
|
|
CREB3L2
|
cAMP responsive element binding protein 3-like 2
|
|
CREBBP
|
CREB binding protein
|
|
CRLF2
|
cytokine receptor-like factor 2
|
|
CRP
|
C-reactive protein, pentraxin-related
|
|
CRYGD
|
crystallin, gamma D
|
|
CSF2
|
colony stimulating factor 2 (granulocyte-macrophage)
|
|
CSF3
|
colony stimulating factor 3 (granulocyte)
|
|
CSNK1E
|
casein kinase 1, epsilon
|
|
CST3
|
cystatin C
|
|
CTAGE5
|
CTAGE family, member 5
|
|
CTLA4
|
cytotoxic T-lymphocyte-associated protein 4
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
CX3CL1
|
chemokine (C-X3-C motif) ligand 1
|
|
CX3CR1
|
chemokine (C-X3-C motif) receptor 1
|
|
CXCL10
|
chemokine (C-X-C motif) ligand 10
|
|
CXCL11
|
chemokine (C-X-C motif) ligand 11
|
|
CXCL12
|
chemokine (C-X-C motif) ligand 12
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
|
CYBB
|
cytochrome b-245, beta polypeptide
|
|
CYP1A1
|
cytochrome P450, family 1, subfamily A, polypeptide 1
|
|
CYP21A2
|
cytochrome P450, family 21, subfamily A, polypeptide 2
|
|
CYP27A1
|
cytochrome P450, family 27, subfamily A, polypeptide 1
|
|
CYP2A6
|
cytochrome P450, family 2, subfamily A, polypeptide 6
|
|
CYP2B6
|
cytochrome P450, family 2, subfamily B, polypeptide 6
|
|
CYP2C19
|
cytochrome P450, family 2, subfamily C, polypeptide 19
|
|
CYP2C8
|
cytochrome P450, family 2, subfamily C, polypeptide 8
|
|
CYP2C9
|
cytochrome P450, family 2, subfamily C, polypeptide 9
|
|
CYP2E1
|
cytochrome P450, family 2, subfamily E, polypeptide 1
|
|
CYP2F1
|
cytochrome P450, family 2, subfamily F, polypeptide 1
|
|
DAPK1
|
death-associated protein kinase 1
|
|
DBH
|
dopamine beta-hydroxylase (dopamine beta-monooxygenase)
|
|
DCLRE1A
|
DNA cross-link repair 1A
|
|
DDX58
|
DEAD (Asp-Glu-Ala-Asp) box polypeptide 58
|
|
DES
|
desmin
|
|
DFNA5
|
deafness, autosomal dominant 5
|
|
DGKE
|
diacylglycerol kinase, epsilon 64kDa
|
|
DGKG
|
diacylglycerol kinase, gamma 90kDa
|
|
DGKZ
|
diacylglycerol kinase, zeta
|
|
DHRS2
|
dehydrogenase/reductase (SDR family) member 2
|
|
DHRS4
|
dehydrogenase/reductase (SDR family) member 4
|
|
DIAPH1
|
diaphanous-related formin 1
|
|
DICER1
|
dicer 1, ribonuclease type III
|
|
DISC1
|
disrupted in schizophrenia 1
|
|
DKK3
|
dickkopf WNT signaling pathway inhibitor 3
|
|
DLD
|
dihydrolipoamide dehydrogenase
|
|
DLG2
|
discs, large homolog 2 (Drosophila)
|
|
DLL1
|
delta-like 1 (Drosophila)
|
|
DLL4
|
delta-like 4 (Drosophila)
|
|
DMPK
|
dystrophia myotonica-protein kinase
|
|
DNA2
|
DNA replication helicase/nuclease 2
|
|
DND1
|
DND microRNA-mediated repression inhibitor 1
|
|
DNMT3A
|
DNA (cytosine-5-)-methyltransferase 3 alpha
|
|
DNMT3B
|
DNA (cytosine-5-)-methyltransferase 3 beta
|
|
DOK1
|
docking protein 1, 62kDa (downstream of tyrosine kinase 1)
|
|
DPP9
|
dipeptidyl-peptidase 9
|
|
DRD2
|
dopamine receptor D2
|
|
DYRK1A
|
dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1A
|
|
DYRK4
|
dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 4
|
|
E2F1
|
E2F transcription factor 1
|
|
E2F3
|
E2F transcription factor 3
|
|
EDNRA
|
endothelin receptor type A
|
|
EEF1A1
|
eukaryotic translation elongation factor 1 alpha 1
|
|
EGF
|
epidermal growth factor
|
|
EGFR
|
epidermal growth factor receptor
|
|
EGLN1
|
egl-9 family hypoxia-inducible factor 1
|
|
EGR2
|
early growth response 2
|
|
EHD3
|
EH-domain containing 3
|
|
EIF2AK2
|
eukaryotic translation initiation factor 2-alpha kinase 2
|
|
EIF2B2
|
eukaryotic translation initiation factor 2B, subunit 2 beta, 39kDa
|
|
EIF6
|
eukaryotic translation initiation factor 6
|
|
ELN
|
elastin
|
|
ELOVL1
|
ELOVL fatty acid elongase 1
|
|
ELOVL4
|
ELOVL fatty acid elongase 4
|
|
EMB
|
embigin
|
|
ENPP1
|
ectonucleotide pyrophosphatase/phosphodiesterase 1
|
|
EP300
|
E1A binding protein p300
|
|
EPCAM
|
epithelial cell adhesion molecule
|
|
EPHA1
|
EPH receptor A1
|
|
EPHX1
|
epoxide hydrolase 1, microsomal (xenobiotic)
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ERCC1
|
excision repair cross-complementation group 1
|
|
ERCC4
|
excision repair cross-complementation group 4
|
|
ERG
|
v-ets avian erythroblastosis virus E26 oncogene homolog
|
|
ESR1
|
estrogen receptor 1
|
|
ESR2
|
estrogen receptor 2 (ER beta)
|
|
ESRRA
|
estrogen-related receptor alpha
|
|
ETV1
|
ets variant 1
|
|
EYS
|
eyes shut homolog (Drosophila)
|
|
EZH2
|
enhancer of zeste 2 polycomb repressive complex 2 subunit
|
|
EZR
|
ezrin
|
|
F13A1
|
coagulation factor XIII, A1 polypeptide
|
|
F3
|
coagulation factor III (thromboplastin, tissue factor)
|
|
F8
|
coagulation factor VIII, procoagulant component
|
|
FAAH
|
fatty acid amide hydrolase
|
|
FADS1
|
fatty acid desaturase 1
|
|
FAF1
|
Fas (TNFRSF6) associated factor 1
|
|
FAM13A
|
family with sequence similarity 13, member A
|
|
FAS
|
Fas cell surface death receptor
|
|
FASN
|
fatty acid synthase
|
|
FBXO7
|
F-box protein 7
|
|
FCGR2A
|
Fc fragment of IgG, low affinity IIa, receptor (CD32)
|
|
FCN2
|
ficolin (collagen/fibrinogen domain containing lectin) 2
|
|
FDCSP
|
follicular dendritic cell secreted protein
|
|
FGA
|
fibrinogen alpha chain
|
|
FGB
|
fibrinogen beta chain
|
|
FGF2
|
fibroblast growth factor 2 (basic)
|
|
FGF23
|
fibroblast growth factor 23
|
|
FGF3
|
fibroblast growth factor 3
|
|
FGF7
|
fibroblast growth factor 7
|
|
FGFR3
|
fibroblast growth factor receptor 3
|
|
FKBP6
|
FK506 binding protein 6, 36kDa
|
|
FKBP8
|
FK506 binding protein 8, 38kDa
|
|
FLG
|
filaggrin
|
|
FLT1
|
fms-related tyrosine kinase 1
|
|
FLT3
|
fms-related tyrosine kinase 3
|
|
FLT4
|
fms-related tyrosine kinase 4
|
|
FMR1
|
fragile X mental retardation 1
|
|
FOXE3
|
forkhead box E3
|
|
FOXO1
|
forkhead box O1
|
|
FOXO3
|
forkhead box O3
|
|
FOXP3
|
forkhead box P3
|
|
FRA1H
|
fragile site, 5-azacytidine type, common, fra(1)(q42)
|
|
FRA2G
|
fragile site, aphidicolin type, common, fra(2)(q31)
|
|
FRK
|
fyn-related Src family tyrosine kinase
|
|
FRZB
|
frizzled-related protein
|
|
FTO
|
fat mass and obesity associated
|
|
FXN
|
frataxin
|
|
FXYD1
|
FXYD domain containing ion transport regulator 1
|
|
FYN
|
FYN proto-oncogene, Src family tyrosine kinase
|
|
G6PD
|
glucose-6-phosphate dehydrogenase
|
|
GAA
|
glucosidase, alpha; acid
|
|
GAD1
|
glutamate decarboxylase 1 (brain, 67kDa)
|
|
GAD2
|
glutamate decarboxylase 2 (pancreatic islets and brain, 65kDa)
|
|
GALT
|
galactose-1-phosphate uridylyltransferase
|
|
GAN
|
gigaxonin
|
|
GATA1
|
GATA binding protein 1 (globin transcription factor 1)
|
|
GDF15
|
growth differentiation factor 15
|
|
GFAP
|
glial fibrillary acidic protein
|
|
GGT1
|
gamma-glutamyltransferase 1
|
|
GH1
|
growth hormone 1
|
|
GHR
|
growth hormone receptor
|
|
GHRL
|
ghrelin/obestatin prepropeptide
|
|
GJA1
|
gap junction protein, alpha 1, 43kDa
|
|
GJB1
|
gap junction protein, beta 1, 32kDa
|
|
GJB2
|
gap junction protein, beta 2, 26kDa
|
|
GNA11
|
guanine nucleotide binding protein (G protein), alpha 11 (Gq class)
|
|
GNAQ
|
guanine nucleotide binding protein (G protein), q polypeptide
|
|
GNB2L1
|
guanine nucleotide binding protein (G protein), beta polypeptide 2-like 1
|
|
GPIHBP1
|
glycosylphosphatidylinositol anchored high density lipoprotein binding protein 1
|
|
GPR143
|
G protein-coupled receptor 143
|
|
GRB2
|
growth factor receptor-bound protein 2
|
|
GRIA4
|
glutamate receptor, ionotropic, AMPA 4
|
|
GRIN3A
|
glutamate receptor, ionotropic, N-methyl-D-aspartate 3A
|
|
GRM3
|
glutamate receptor, metabotropic 3
|
|
GSTM1
|
glutathione S-transferase mu 1
|
|
GSTT1
|
glutathione S-transferase theta 1
|
|
GYG1
|
glycogenin 1
|
|
GZMA
|
granzyme A (granzyme 1, cytotoxic T-lymphocyte-associated serine esterase 3)
|
|
H19
|
H19, imprinted maternally expressed transcript (non-protein coding)
|
|
H1FOO
|
H1 histone family, member O, oocyte-specific
|
|
H2AFX
|
H2A histone family, member X
|
|
H6PD
|
hexose-6-phosphate dehydrogenase (glucose 1-dehydrogenase)
|
|
HACD1
|
3-hydroxyacyl-CoA dehydratase 1
|
|
HACE1
|
HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1
|
|
HBA1
|
hemoglobin, alpha 1
|
|
HBA2
|
hemoglobin, alpha 2
|
|
HBB
|
hemoglobin, beta
|
|
HBG1
|
hemoglobin, gamma A
|
|
HCCAT5
|
hepatocellular carcinoma associated transcript 5 (non-protein coding)
|
|
HES1
|
hes family bHLH transcription factor 1
|
|
HFE
|
hemochromatosis
|
|
HGF
|
hepatocyte growth factor (hepapoietin A; scatter factor)
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
|
HLA-B
|
major histocompatibility complex, class I, B
|
|
HLA-C
|
major histocompatibility complex, class I, C
|
|
HLA-DQB1
|
major histocompatibility complex, class II, DQ beta 1
|
|
HLA-DRB1
|
major histocompatibility complex, class II, DR beta 1
|
|
HLA-DRB3
|
major histocompatibility complex, class II, DR beta 3
|
|
HLA-E
|
major histocompatibility complex, class I, E
|
|
HLA-G
|
major histocompatibility complex, class I, G
|
|
HMGCL
|
3-hydroxymethyl-3-methylglutaryl-CoA lyase
|
|
HMMR
|
hyaluronan-mediated motility receptor (RHAMM)
|
|
HNF1B
|
HNF1 homeobox B
|
|
HNF4A
|
hepatocyte nuclear factor 4, alpha
|
|
HNRNPH1
|
heterogeneous nuclear ribonucleoprotein H1 (H)
|
|
HPGD
|
hydroxyprostaglandin dehydrogenase 15-(NAD)
|
|
HRAS
|
Harvey rat sarcoma viral oncogene homolog
|
|
HS3ST5
|
heparan sulfate (glucosamine) 3-O-sulfotransferase 5
|
|
HSD17B12
|
hydroxysteroid (17-beta) dehydrogenase 12
|
|
HSPA1A
|
heat shock 70kDa protein 1A
|
|
HSPA4
|
heat shock 70kDa protein 4
|
|
HSPA5
|
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa)
|
|
HSPD1
|
heat shock 60kDa protein 1 (chaperonin)
|
|
HTRA1
|
HtrA serine peptidase 1
|
|
HTRA2
|
HtrA serine peptidase 2
|
|
HYDIN
|
HYDIN, axonemal central pair apparatus protein
|
|
IDH1
|
isocitrate dehydrogenase 1 (NADP+), soluble
|
|
IDH2
|
isocitrate dehydrogenase 2 (NADP+), mitochondrial
|
|
IDO1
|
indoleamine 2,3-dioxygenase 1
|
|
IDS
|
iduronate 2-sulfatase
|
|
IFI30
|
interferon, gamma-inducible protein 30
|
|
IFNB1
|
interferon, beta 1, fibroblast
|
|
IFNG
|
interferon, gamma
|
|
IFNL3
|
interferon, lambda 3
|
|
IFNW1
|
interferon, omega 1
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
|
IGF2
|
insulin-like growth factor 2
|
|
IGFALS
|
insulin-like growth factor binding protein, acid labile subunit
|
|
IGFBP5
|
insulin-like growth factor binding protein 5
|
|
IKZF1
|
IKAROS family zinc finger 1 (Ikaros)
|
|
IL10
|
interleukin 10
|
|
IL10RA
|
interleukin 10 receptor, alpha
|
|
IL10RB
|
interleukin 10 receptor, beta
|
|
IL12B
|
interleukin 12B
|
|
IL13RA2
|
interleukin 13 receptor, alpha 2
|
|
IL17A
|
interleukin 17A
|
|
IL1A
|
interleukin 1, alpha
|
|
IL1B
|
interleukin 1, beta
|
|
IL2
|
interleukin 2
|
|
IL23R
|
interleukin 23 receptor
|
|
IL36RN
|
interleukin 36 receptor antagonist
|
|
IL4
|
interleukin 4
|
|
IL6
|
interleukin 6
|
|
IL7
|
interleukin 7
|
|
IRAK1
|
interleukin-1 receptor-associated kinase 1
|
|
IRGM
|
immunity-related GTPase family, M
|
|
ITGA4
|
integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor)
|
|
ITGAL
|
integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide)
|
|
ITGAV
|
integrin, alpha V
|
|
ITGB1
|
integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)
|
|
ITGB3
|
integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61)
|
|
ITPA
|
inosine triphosphatase (nucleoside triphosphate pyrophosphatase)
|
|
ITPR1
|
inositol 1,4,5-trisphosphate receptor, type 1
|
|
JAG2
|
jagged 2
|
|
JAK2
|
Janus kinase 2
|
|
JAK3
|
Janus kinase 3
|
|
KCNA5
|
potassium channel, voltage gated shaker related subfamily A, member 5
|
|
KCNH2
|
potassium channel, voltage gated eag related subfamily H, member 2
|
|
KCNJ2
|
potassium channel, inwardly rectifying subfamily J, member 2
|
|
KCNJ3
|
potassium channel, inwardly rectifying subfamily J, member 3
|
|
KCNQ1
|
potassium channel, voltage gated KQT-like subfamily Q, member 1
|
|
KCNQ2
|
potassium channel, voltage gated KQT-like subfamily Q, member 2
|
|
KDM1A
|
lysine (K)-specific demethylase 1A
|
|
KDR
|
kinase insert domain receptor
|
|
KISS1
|
KiSS-1 metastasis-suppressor
|
|
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
|
KLF1
|
Kruppel-like factor 1 (erythroid)
|
|
KLK1
|
kallikrein 1
|
|
KLK10
|
kallikrein-related peptidase 10
|
|
KLK13
|
kallikrein-related peptidase 13
|
|
KLK14
|
kallikrein-related peptidase 14
|
|
KLK2
|
kallikrein-related peptidase 2
|
|
KLK3
|
kallikrein-related peptidase 3
|
|
KLK5
|
kallikrein-related peptidase 5
|
|
KLK6
|
kallikrein-related peptidase 6
|
|
KLK7
|
kallikrein-related peptidase 7
|
|
KLK8
|
kallikrein-related peptidase 8
|
|
KMT2A
|
lysine (K)-specific methyltransferase 2A
|
|
KPNA1
|
karyopherin alpha 1 (importin alpha 5)
|
|
KPNA4
|
karyopherin alpha 4 (importin alpha 3)
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
|
KRT19
|
keratin 19, type I
|
|
KRT5
|
keratin 5, type II
|
|
KRT7
|
keratin 7, type II
|
|
LBP
|
lipopolysaccharide binding protein
|
|
LCAT
|
lecithin-cholesterol acyltransferase
|
|
LCK
|
LCK proto-oncogene, Src family tyrosine kinase
|
|
LCN2
|
lipocalin 2
|
|
LDLR
|
low density lipoprotein receptor
|
|
LEFTY1
|
left-right determination factor 1
|
|
LEFTY2
|
left-right determination factor 2
|
|
LEP
|
leptin
|
|
LGALS3
|
lectin, galactoside-binding, soluble, 3
|
|
LHCGR
|
luteinizing hormone/choriogonadotropin receptor
|
|
LIF
|
leukemia inhibitory factor
|
|
LIN28A
|
lin-28 homolog A (C. elegans)
|
|
LMNA
|
lamin A/C
|
|
LOX
|
lysyl oxidase
|
|
LOXL1
|
lysyl oxidase-like 1
|
|
LPL
|
lipoprotein lipase
|
|
LRP1
|
low density lipoprotein receptor-related protein 1
|
|
LRP8
|
low density lipoprotein receptor-related protein 8, apolipoprotein e receptor
|
|
LRRK2
|
leucine-rich repeat kinase 2
|
|
MAP2K7
|
mitogen-activated protein kinase kinase 7
|
|
MAP3K14
|
mitogen-activated protein kinase kinase kinase 14
|
|
MAPT
|
microtubule-associated protein tau
|
|
MARS
|
methionyl-tRNA synthetase
|
|
MASP1
|
mannan-binding lectin serine peptidase 1 (C4/C2 activating component of Ra-reactive factor)
|
|
MASP2
|
mannan-binding lectin serine peptidase 2
|
|
MAVS
|
mitochondrial antiviral signaling protein
|
|
MBL2
|
mannose-binding lectin (protein C) 2, soluble
|
|
MCM9
|
minichromosome maintenance complex component 9
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
|
MDM4
|
MDM4, p53 regulator
|
|
MECP2
|
methyl CpG binding protein 2
|
|
MEF2C
|
myocyte enhancer factor 2C
|
|
MEIS1
|
Meis homeobox 1
|
|
MERTK
|
MER proto-oncogene, tyrosine kinase
|
|
MET
|
MET proto-oncogene, receptor tyrosine kinase
|
|
MIR125B1
|
microRNA 125b-1
|
|
MIR147B
|
microRNA 147b
|
|
MIR18A
|
microRNA 18a
|
|
MIR210
|
microRNA 210
|
|
MIR223
|
microRNA 223
|
|
MIR34A
|
microRNA 34a
|
|
MKI67
|
marker of proliferation Ki-67
|
|
MLANA
|
melan-A
|
|
MLH1
|
mutL homolog 1
|
|
MMACHC
|
methylmalonic aciduria (cobalamin deficiency) cblC type, with homocystinuria
|
|
MMP2
|
matrix metallopeptidase 2
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MOG
|
myelin oligodendrocyte glycoprotein
|
|
MPO
|
myeloperoxidase
|
|
MRPL41
|
mitochondrial ribosomal protein L41
|
|
MSH2
|
mutS homolog 2
|
|
MSTN
|
myostatin
|
|
MT-CYB
|
cytochrome b
|
|
MTHFR
|
methylenetetrahydrofolate reductase (NAD(P)H)
|
|
MUC1
|
mucin 1, cell surface associated
|
|
MUC2
|
mucin 2, oligomeric mucus/gel-forming
|
|
MUC5B
|
mucin 5B, oligomeric mucus/gel-forming
|
|
MUTYH
|
mutY homolog
|
|
MVK
|
mevalonate kinase
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
MYCN
|
v-myc avian myelocytomatosis viral oncogene neuroblastoma derived homolog
|
|
MYOC
|
myocilin, trabecular meshwork inducible glucocorticoid response
|
|
MYOT
|
myotilin
|
|
MYOZ1
|
myozenin 1
|
|
MYOZ2
|
myozenin 2
|
|
NBN
|
nibrin
|
|
ND1
|
|
|
NDP
|
Norrie disease (pseudoglioma)
|
|
NEIL1
|
nei endonuclease VIII-like 1 (E. coli)
|
|
NELFE
|
negative elongation factor complex member E
|
|
NES
|
nestin
|
|
NEU2
|
sialidase 2 (cytosolic sialidase)
|
|
NEWENTRY
|
Record to support submission of GeneRIFs for a gene not in Gene (human; man).
|
|
NF2
|
neurofibromin 2 (merlin)
|
|
NFKBIA
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha
|
|
NKX2-5
|
NK2 homeobox 5
|
|
NLGN3
|
neuroligin 3
|
|
NLGN4X
|
neuroligin 4, X-linked
|
|
NNMT
|
nicotinamide N-methyltransferase
|
|
NOBOX
|
NOBOX oogenesis homeobox
|
|
NOD2
|
nucleotide-binding oligomerization domain containing 2
|
|
NOS2
|
nitric oxide synthase 2, inducible
|
|
NOS3
|
nitric oxide synthase 3 (endothelial cell)
|
|
NOX1
|
NADPH oxidase 1
|
|
NOX4
|
NADPH oxidase 4
|
|
NPM1
|
nucleophosmin (nucleolar phosphoprotein B23, numatrin)
|
|
NPPB
|
natriuretic peptide B
|
|
NPPC
|
natriuretic peptide C
|
|
NR1H4
|
nuclear receptor subfamily 1, group H, member 4
|
|
NR1I2
|
nuclear receptor subfamily 1, group I, member 2
|
|
NRAS
|
neuroblastoma RAS viral (v-ras) oncogene homolog
|
|
NRG1
|
neuregulin 1
|
|
NRP2
|
neuropilin 2
|
|
NUCB2
|
nucleobindin 2
|
|
NUMB
|
numb homolog (Drosophila)
|
|
NXPH1
|
neurexophilin 1
|
|
OBSCN
|
obscurin, cytoskeletal calmodulin and titin-interacting RhoGEF
|
|
OCA2
|
oculocutaneous albinism II
|
|
OCIAD1
|
OCIA domain containing 1
|
|
OCIAD2
|
OCIA domain containing 2
|
|
OCRL
|
oculocerebrorenal syndrome of Lowe
|
|
OGG1
|
8-oxoguanine DNA glycosylase
|
|
OPA1
|
optic atrophy 1 (autosomal dominant)
|
|
OPA3
|
optic atrophy 3 (autosomal recessive, with chorea and spastic paraplegia)
|
|
ORAI1
|
ORAI calcium release-activated calcium modulator 1
|
|
OXER1
|
oxoeicosanoid (OXE) receptor 1
|
|
OXTR
|
oxytocin receptor
|
|
PAH
|
phenylalanine hydroxylase
|
|
PAOX
|
polyamine oxidase (exo-N4-amino)
|
|
PARK2
|
parkin RBR E3 ubiquitin protein ligase
|
|
PARK7
|
parkinson protein 7
|
|
PARP1
|
poly (ADP-ribose) polymerase 1
|
|
PAX4
|
paired box 4
|
|
PCNA
|
proliferating cell nuclear antigen
|
|
PCSK4
|
proprotein convertase subtilisin/kexin type 4
|
|
PCYOX1
|
prenylcysteine oxidase 1
|
|
PDGFB
|
platelet-derived growth factor beta polypeptide
|
|
PDGFRA
|
platelet-derived growth factor receptor, alpha polypeptide
|
|
PDPN
|
podoplanin
|
|
PDYN
|
prodynorphin
|
|
PFN1
|
profilin 1
|
|
PGF
|
placental growth factor
|
|
PGK1
|
phosphoglycerate kinase 1
|
|
PGR
|
progesterone receptor
|
|
PHEX
|
phosphate regulating endopeptidase homolog, X-linked
|
|
PHGDH
|
phosphoglycerate dehydrogenase
|
|
PIGA
|
phosphatidylinositol glycan anchor biosynthesis, class A
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
|
PIN1
|
peptidylprolyl cis/trans isomerase, NIMA-interacting 1
|
|
PINK1
|
PTEN induced putative kinase 1
|
|
PLA2G2A
|
phospholipase A2, group IIA (platelets, synovial fluid)
|
|
PLAC1
|
placenta-specific 1
|
|
PLAG1
|
pleiomorphic adenoma gene 1
|
|
PLTP
|
phospholipid transfer protein
|
|
PMEL
|
premelanosome protein
|
|
PMEPA1
|
prostate transmembrane protein, androgen induced 1
|
|
PML
|
promyelocytic leukemia
|
|
PMP22
|
peripheral myelin protein 22
|
|
POLB
|
polymerase (DNA directed), beta
|
|
POLG
|
polymerase (DNA directed), gamma
|
|
POLH
|
polymerase (DNA directed), eta
|
|
POLL
|
polymerase (DNA directed), lambda
|
|
POMC
|
proopiomelanocortin
|
|
PON1
|
paraoxonase 1
|
|
PON3
|
paraoxonase 3
|
|
PPARD
|
peroxisome proliferator-activated receptor delta
|
|
PPARG
|
peroxisome proliferator-activated receptor gamma
|
|
PPARGC1A
|
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha
|
|
PPM1D
|
protein phosphatase, Mg2+/Mn2+ dependent, 1D
|
|
PRDX1
|
peroxiredoxin 1
|
|
PRKAG2
|
protein kinase, AMP-activated, gamma 2 non-catalytic subunit
|
|
PRKCA
|
protein kinase C, alpha
|
|
PRLR
|
prolactin receptor
|
|
PRNP
|
prion protein
|
|
PROC
|
protein C (inactivator of coagulation factors Va and VIIIa)
|
|
PROCR
|
protein C receptor, endothelial
|
|
PROM1
|
prominin 1
|
|
PROP1
|
PROP paired-like homeobox 1
|
|
PRTFDC1
|
phosphoribosyl transferase domain containing 1
|
|
PSEN1
|
presenilin 1
|
|
PSEN2
|
presenilin 2
|
|
PSMA3
|
proteasome (prosome, macropain) subunit, alpha type, 3
|
|
PSMB7
|
proteasome (prosome, macropain) subunit, beta type, 7
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTGS1
|
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTH
|
parathyroid hormone
|
|
PTK2B
|
protein tyrosine kinase 2 beta
|
|
PTPN13
|
protein tyrosine phosphatase, non-receptor type 13 (APO-1/CD95 (Fas)-associated phosphatase)
|
|
PTPRC
|
protein tyrosine phosphatase, receptor type, C
|
|
PTPRD
|
protein tyrosine phosphatase, receptor type, D
|
|
PUM2
|
pumilio RNA-binding family member 2
|
|
PVRL1
|
poliovirus receptor-related 1 (herpesvirus entry mediator C)
|
|
PYCARD
|
PYD and CARD domain containing
|
|
RAD18
|
RAD18 E3 ubiquitin protein ligase
|
|
RAD51C
|
RAD51 paralog C
|
|
RAD51D
|
RAD51 paralog D
|
|
RAET1G
|
retinoic acid early transcript 1G
|
|
RAP1GAP
|
RAP1 GTPase activating protein
|
|
RB1
|
retinoblastoma 1
|
|
RB1CC1
|
RB1-inducible coiled-coil 1
|
|
RBM10
|
RNA binding motif protein 10
|
|
RBP4
|
retinol binding protein 4, plasma
|
|
RD3
|
retinal degeneration 3
|
|
RELN
|
reelin
|
|
REST
|
RE1-silencing transcription factor
|
|
RET
|
ret proto-oncogene
|
|
RETN
|
resistin
|
|
RGN
|
regucalcin
|
|
RGS4
|
regulator of G-protein signaling 4
|
|
RHD
|
Rh blood group, D antigen
|
|
RHOA
|
ras homolog family member A
|
|
RHOC
|
ras homolog family member C
|
|
RLBP1
|
retinaldehyde binding protein 1
|
|
RPA1
|
replication protein A1, 70kDa
|
|
RUNX1T1
|
runt-related transcription factor 1; translocated to, 1 (cyclin D-related)
|
|
RUNX2
|
runt-related transcription factor 2
|
|
RXFP1
|
relaxin/insulin-like family peptide receptor 1
|
|
SAG
|
S-antigen; retina and pineal gland (arrestin)
|
|
SCARB1
|
scavenger receptor class B, member 1
|
|
SCGB2A2
|
secretoglobin, family 2A, member 2
|
|
SCN5A
|
sodium channel, voltage gated, type V alpha subunit
|
|
SCPEP1
|
serine carboxypeptidase 1
|
|
SDHC
|
succinate dehydrogenase complex, subunit C, integral membrane protein, 15kDa
|
|
SEL1L
|
sel-1 suppressor of lin-12-like (C. elegans)
|
|
SELP
|
selectin P (granule membrane protein 140kDa, antigen CD62)
|
|
SERPINA1
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1
|
|
SERPINA3
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 3
|
|
SERPINE1
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
|
|
SHC1
|
SHC (Src homology 2 domain containing) transforming protein 1
|
|
SHOX
|
short stature homeobox
|
|
SIGMAR1
|
sigma non-opioid intracellular receptor 1
|
|
SIL1
|
SIL1 nucleotide exchange factor
|
|
SIRT1
|
sirtuin 1
|
|
SLC22A18AS
|
solute carrier family 22 (organic cation transporter), member 18 antisense
|
|
SLC22A5
|
solute carrier family 22 (organic cation/carnitine transporter), member 5
|
|
SLC27A4
|
solute carrier family 27 (fatty acid transporter), member 4
|
|
SLC2A2
|
solute carrier family 2 (facilitated glucose transporter), member 2
|
|
SLC38A1
|
solute carrier family 38, member 1
|
|
SLC6A4
|
solute carrier family 6 (neurotransmitter transporter), member 4
|
|
SLC9A3R1
|
solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member 3 regulator 1
|
|
SLCO1B1
|
solute carrier organic anion transporter family, member 1B1
|
|
SLX4
|
SLX4 structure-specific endonuclease subunit
|
|
SMAD4
|
SMAD family member 4
|
|
SMARCB1
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1
|
|
SMN1
|
survival of motor neuron 1, telomeric
|
|
SMO
|
smoothened, frizzled class receptor
|
|
SMPD1
|
sphingomyelin phosphodiesterase 1, acid lysosomal
|
|
SNCA
|
synuclein, alpha (non A4 component of amyloid precursor)
|
|
SOAT1
|
sterol O-acyltransferase 1
|
|
SOAT2
|
sterol O-acyltransferase 2
|
|
SOCS3
|
suppressor of cytokine signaling 3
|
|
SOD1
|
superoxide dismutase 1, soluble
|
|
SOD2
|
superoxide dismutase 2, mitochondrial
|
|
SOD3
|
superoxide dismutase 3, extracellular
|
|
SOX10
|
SRY (sex determining region Y)-box 10
|
|
SPINT1
|
serine peptidase inhibitor, Kunitz type 1
|
|
SPTA1
|
spectrin, alpha, erythrocytic 1
|
|
SPTB
|
spectrin, beta, erythrocytic
|
|
SRF
|
serum response factor (c-fos serum response element-binding transcription factor)
|
|
SSTR3
|
somatostatin receptor 3
|
|
ST14
|
suppression of tumorigenicity 14 (colon carcinoma)
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
STMN1
|
stathmin 1
|
|
SUCLG1
|
succinate-CoA ligase, alpha subunit
|
|
SUMO1
|
small ubiquitin-like modifier 1
|
|
SYCP3
|
synaptonemal complex protein 3
|
|
TARDBP
|
TAR DNA binding protein
|
|
TBP
|
TATA box binding protein
|
|
TBXA2R
|
thromboxane A2 receptor
|
|
TCEA2
|
transcription elongation factor A (SII), 2
|
|
TCF21
|
transcription factor 21
|
|
TECR
|
trans-2,3-enoyl-CoA reductase
|
|
TEK
|
TEK tyrosine kinase, endothelial
|
|
TERC
|
telomerase RNA component
|
|
TERT
|
telomerase reverse transcriptase
|
|
TEX40
|
testis expressed 40
|
|
TF
|
transferrin
|
|
TFF1
|
trefoil factor 1
|
|
TFRC
|
transferrin receptor
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TGM5
|
transglutaminase 5
|
|
THAP1
|
THAP domain containing, apoptosis associated protein 1
|
|
THPO
|
thrombopoietin
|
|
TIE1
|
tyrosine kinase with immunoglobulin-like and EGF-like domains 1
|
|
TINF2
|
TERF1 (TRF1)-interacting nuclear factor 2
|
|
TK1
|
thymidine kinase 1, soluble
|
|
TLR2
|
toll-like receptor 2
|
|
TLR4
|
toll-like receptor 4
|
|
TLR5
|
toll-like receptor 5
|
|
TLR9
|
toll-like receptor 9
|
|
TMEM231
|
transmembrane protein 231
|
|
TMPRSS2
|
transmembrane protease, serine 2
|
|
TMPRSS6
|
transmembrane protease, serine 6
|
|
TNF
|
tumor necrosis factor
|
|
TNFRSF13B
|
tumor necrosis factor receptor superfamily, member 13B
|
|
TNFSF13
|
tumor necrosis factor (ligand) superfamily, member 13
|
|
TNFSF13B
|
tumor necrosis factor (ligand) superfamily, member 13b
|
|
TNFSF14
|
tumor necrosis factor (ligand) superfamily, member 14
|
|
TNFSF4
|
tumor necrosis factor (ligand) superfamily, member 4
|
|
TNNI3
|
troponin I type 3 (cardiac)
|
|
TNNT2
|
troponin T type 2 (cardiac)
|
|
TOMM40
|
translocase of outer mitochondrial membrane 40 homolog (yeast)
|
|
TOP1
|
topoisomerase (DNA) I
|
|
TOR1A
|
torsin family 1, member A (torsin A)
|
|
TP53
|
tumor protein p53
|
|
TP63
|
tumor protein p63
|
|
TPI1
|
triosephosphate isomerase 1
|
|
TPM1
|
tropomyosin 1 (alpha)
|
|
TPM2
|
tropomyosin 2 (beta)
|
|
TPM3
|
tropomyosin 3
|
|
TPO
|
thyroid peroxidase
|
|
TPP2
|
tripeptidyl peptidase II
|
|
TPT1
|
tumor protein, translationally-controlled 1
|
|
TRIM13
|
tripartite motif containing 13
|
|
TRIM28
|
tripartite motif containing 28
|
|
TRIM5
|
tripartite motif containing 5
|
|
TRPC6
|
transient receptor potential cation channel, subfamily C, member 6
|
|
TSC1
|
tuberous sclerosis 1
|
|
TSC2
|
tuberous sclerosis 2
|
|
TSPYL1
|
TSPY-like 1
|
|
TTC7A
|
tetratricopeptide repeat domain 7A
|
|
TTK
|
TTK protein kinase
|
|
TTN
|
titin
|
|
TTR
|
transthyretin
|
|
TUBB2A
|
tubulin, beta 2A class IIa
|
|
TWIST2
|
twist family bHLH transcription factor 2
|
|
U2AF2
|
U2 small nuclear RNA auxiliary factor 2
|
|
UBTD2
|
ubiquitin domain containing 2
|
|
UBTF
|
upstream binding transcription factor, RNA polymerase I
|
|
UCP1
|
uncoupling protein 1 (mitochondrial, proton carrier)
|
|
UCP2
|
uncoupling protein 2 (mitochondrial, proton carrier)
|
|
UCP3
|
uncoupling protein 3 (mitochondrial, proton carrier)
|
|
UGT1A1
|
UDP glucuronosyltransferase 1 family, polypeptide A1
|
|
UMOD
|
uromodulin
|
|
UNC5C
|
unc-5 homolog C (C. elegans)
|
|
USB1
|
U6 snRNA biogenesis 1
|
|
VANGL1
|
VANGL planar cell polarity protein 1
|
|
VCAM1
|
vascular cell adhesion molecule 1
|
|
VCP
|
valosin containing protein
|
|
VDR
|
vitamin D (1,25- dihydroxyvitamin D3) receptor
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
VHL
|
von Hippel-Lindau tumor suppressor, E3 ubiquitin protein ligase
|
|
VIP
|
vasoactive intestinal peptide
|
|
VKORC1
|
vitamin K epoxide reductase complex, subunit 1
|
|
VLDLR
|
very low density lipoprotein receptor
|
|
VSX1
|
visual system homeobox 1
|
|
VWF
|
von Willebrand factor
|
|
WDR33
|
WD repeat domain 33
|
|
WHSC1
|
Wolf-Hirschhorn syndrome candidate 1
|
|
WIF1
|
WNT inhibitory factor 1
|
|
WNT4
|
wingless-type MMTV integration site family, member 4
|
|
WNT5A
|
wingless-type MMTV integration site family, member 5A
|
|
WT1
|
Wilms tumor 1
|
|
XIAP
|
X-linked inhibitor of apoptosis, E3 ubiquitin protein ligase
|
|
XPA
|
xeroderma pigmentosum, complementation group A
|
|
YWHAE
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon
|
|
YWHAG
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, gamma
|
|
YY1
|
YY1 transcription factor
|
|
ZBTB16
|
zinc finger and BTB domain containing 16
|
|
ZMYND11
|
zinc finger, MYND-type containing 11
|
|
ZNF382
|
zinc finger protein 382
|
|
ZYX
|
zyxin
|
